1. Adams, R.M., Burdick, K. H.: An antiandrogen, delta-1-Chlormadinone acetate in acne: lack of effect topically. Acta derm., venereol. (Stockh.) 50, 479–480 (1970).

   CAS  Google Scholar 

2. Albin, J., Vittek, J., Gordon, G.G., Altman, K., Olivo, J., Southren, A.L.: On the mechanism of the anti-androgenic effect of medroxyprogesterone acetate. Endocrinology93, 417–422 (1973).

   Article PubMed CAS  Google Scholar 

3. Anderson, K.M., Liao, S.: Selective retention of dihydrotestosterone by prostatic nuclei. Nature (Lond.)219, 277–279 (1968).

   Article CAS  Google Scholar 

4. Apostolakis, M., Ludwig, E., Voigt, K.D.: Testosterone-, Oestrogen- und Gonadotropinausscheidung bei diffuser weiblicher Alopecie. Klin. Wschr.43, 9–15 (1965).

   Article PubMed CAS  Google Scholar 

5. Apostolakis, M., Ludwig, E., Voigt, K.D.: Excerpta Med. Found. Intern. Congr. Ser. 6 Nr. 111, 327 (1966).

   Google Scholar 

6. Apostolakis, M., Tamm, J., Voigt, K.D.: Biochemical and clinical studies with cyproterone. Acta endocr. (Kbh.)56, Suppl. 199, Abstract Nr. 40 (1967).

   Google Scholar 

7. Apostolakis, M., Tamm, J., Voigt, K.D.: The effects of HCG in cyproterone treated male subjects. Testosterone. In: Tamm, J. (Ed.). Proc. Workshop Conf. Tremsbüttel 1967. Stuttgart (1968), pp. 156–161.

   Google Scholar 

8. Aznar-Ramos R., Giner-Velazques, J., Martinez-Manautou, J.: Contraception efficacy of single and divided doses of Chlormadinone acetate. Contraception4, 37–43 (1971).

   Article  Google Scholar 

9. Baillie, A.H., Calman, K.C., Milne, J.A.: Histochemical distribution of hydroxy - steroid dehydrogenases in human skin. Brit. J. Derm.77, 610–616 (1965).

   Article PubMed CAS  Google Scholar 

10. Bardin, C.W., Kirschner, M.A.: In: Sunderman, F., Sunderman, F.W. (Eds.). Laboratory Diagnosis of Endocrine Diseases, ch. 51. St. Louis: H. Green Inc. 1971.

    Google Scholar 

11. Bardin, C.W., Lepsett, M.B.: Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism of polycystic ovaries. J. clin. Invest.46, 891–902 (1967).

    Article PubMed CAS  Google Scholar 

12. Beck, P.: Comparison of the metabolic effects of Chlormadinone acetate and conventional contraceptive steroids in man. J. clin. Endocr.30, 785–791 (1970).

    Article PubMed CAS  Google Scholar 

13. Beck, A., Friedrich, F., Caucig, H.: Cyproteronazetat als Einmalpille. (Oral contraception by a single dose of cyproterone acetate). Geburtsh. u. Frauenlieilk.32, 138–144 (1972).

    CAS  Google Scholar 

14. Bettendorf, G.: Effect of cyproterone in female virilizing syndromes. In: Cassano, C., Finkelstein, M., Klopper, A. (Eds.). Research on Steroids. Amsterdam: North-Holland Publ. 3, 267–276 (1968).

    Google Scholar 

15. Bettendorf, G., Breckwoldt, M., Czygan, P. J., Groot, K., Schulz, K.D.: Klinischexperimentelle Untersuchungen mit dem Antiandrogen “Cyproteron”. In: Klein, E. (Ed.). Das Testosteron. Die Struma, S. 102–108. Berlin-Heidelberg-New York: Springer 1968.

    Google Scholar 

16. Beyer, J., Demisch, K., Wiegelmann, W., Happ, J., Kollmann, F., Schöffling, K.: Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty. Acta endocr. (Kbh.) Suppl.173, 169 (1973).

    CAS  Google Scholar 

17. Bierich, J. R.: Pubertas praecox and pubertas tarda (precocious and retarded puberty). Symp. Deut. Gesell. Endokrinol. 16, 183–194. Berlin-Heidelberg-New York: Springer 1970.

    Google Scholar 

18. Bierich, J.R.: Diagnostic and therapeutic use of antiandrogens. 13th Int. Cong, of Paediatrics, Wien 1971, p. 37.

    Google Scholar 

19. Bierich, J.R., Blunck, W., Schönberg, D.: Über Frühreife. Mschr. Kinderheilk.115, 509–516 (1967).

    CAS  Google Scholar 

20. Bierich, J.R., Gupta, D., Heller, S.: Prüfung des Hypothalamus-Hypophyse-Gonadensystems bei Knaben vor der Pubertät mit Cyproteron. Preview of the “Symposium der Europäischen Gesellschaft für pädiatrische Endokrinologie”, Zürich, Mai 1971.

    Google Scholar 

21. Bierich, J.R., Gupta, D., Heller, S.: Examination by cyproterone of the hypothalamo hypophyseo-gonadal system in prepubertal boys. Acta paediat. scand.61, 265–266 (1972).

    Google Scholar 

22. Bierich, J.R., Schönberg, D., Blunck, W.: Pubertas praecox infolge von Hamartomen des Hypothalamus. Precocious puberty due to hamartomas of the hypothalamus. In: Kracht, J. Oestrogene Hypophysentumoren. 15. Symp. Deut. Gesell. Endokrinol., Köln 1969. Berlin-Heidelberg-New York: Springer, S. 301 (1969).

    Google Scholar 

23. Bossi, E., Zurbrügg, R.P.: Behandlung der Pubertas praecox mit dem Antiandrogen Cyproteronacetat. Klin. Wschr.51, 774 (1973).

    Google Scholar 

24. Bossi, E., Joss, E. E., Zurbrügg, R.P.: Evaluation of the effectiveness of treatment on adult height prognosis in disorders with advanced and retarded bone age. Acta paediat. scand.62, 401–404 (1973).

    Article PubMed CAS  Google Scholar 

25. Bossi, E., Zurbrügg, R.P., Joss, E.E.: Improvement of adult height prognosis in precocious puberty by cyproterone acetate. Acta paediat. scand.62, 405–412 (1973).

    Article PubMed CAS  Google Scholar 

26. Bossi, E., Zurbrügg, R.P., Joss, E.E.: Cyproteronacetat und Pubertas praecox. Med. Mitt. Schering, Nr.2, 19–25 (1973).

    Google Scholar 

27. Bracci, U., Di Selverio, F.: IL nostro attuale orientamento in tema di terapia ormonale del cancro della prostata. Preview of the Congress di Chirurgia Internazonale, Roma 1972.

    Google Scholar 

28. Bracci, U., Di Silverio, F.: Il nostro attuale orientamento nella terapia del carcinoma della prostata. Preview of the Congresso della Sozietà Italiano di Urologia, Genova 1973.

    Google Scholar 

29. Briggs, M.H., Brotherton, J. : Steroid biochemistry and pharmacology. London New York: Academic Press 1970, p. 52–108.

    Google Scholar 

30. Brotherton, J. : Bibliography (with review) on animal experiments with anti-androgens. Bibliogr. Reprod. 21, 173–186 (1973) and 359–370 (1973).

    Google Scholar 

31. Brotherton, J.: Bibliography (with reviews) on clinical uses of anti-androgens. Bibliogr. Reprod.20, 913–924 (1972) and 1113–1122 (1972).

    Google Scholar 

32. Brotherton, J. : Effect of oral cyproterone acetate on urinary and serum FSH and LH levels in adult males being treated for hypersexuality. J. Reprod. Fertil.36, 177–187 (1974).

    Article PubMed CAS  Google Scholar 

33. Brotherton, J.: Sex hormone pharmacology. London-New York: Academic Press 1974 (in press).

    Google Scholar 

34. Brotherton, J., Barnard, G. : Some aspects of the effect of cyproterone acetate on levels of other steroid hormones in man. J. Reprod. Fertil.36, 373–385 (1974).

    Article PubMed CAS  Google Scholar 

35. Brotherton, J., Harcus, A.W.: Effect of oral cyproterone acetate on urinary FSH and LH levels in adult males being treated for hypersexuality. J. Reprod. Fertil.33, 356–357 (1973).

    Article  Google Scholar 

36. Brooks, J.R., Busch, R.D., Patanelli, D.J., Steelman, S.L.: A study on the effects of a new anti-androgen on the hyperplastic dog prostate. Proc. Soc. exp. Biol. (N.Y.)143, 647–655 (1973).

    CAS  Google Scholar 

37. Bruchovsky, N., Wilson, J.B. : The intranuclear binding of testosterone and 5a-androstan-17β-OL-3-one by rat prostate. J. biol. Chem.243, 5953–5960 (1968).

    PubMed CAS  Google Scholar 

38. Burchardt, P., Agrapidakis, J.: Leber und Nierenfunktion nach oraler Gabe des anti-androgens Cyproteronacetat. Proc. Soc. exp. Biol. (N.Y.)143, 647–655 (1972).

    Google Scholar 

39. Burton, J.L., Laschet, U., Shuster, S. : Reduction of sebum excretion in man by the antiandrogen, cyproterone acetate. Brit. J. Derm.89, 487 (1973).

    Article PubMed CAS  Google Scholar 

40. Calman, K. C. : Androgens and acne : A new method for the screening of antiandrogens in human skin. Brit. J. Derm.82, Suppl. 6, 26–32 (1970).

    Article CAS  Google Scholar 

41. Caplan, R.M. : Gynecomastia from a non-estrogenic anti-androgen. J. clin. Endocr.27, 1348–1349 (1967).

    Article PubMed CAS  Google Scholar 

42. Chagoya, L., Nurko, B., Santos, E., Rivera, A.: 6-Chloro-6-dehydro-17α-acetoxy-progesterone : Its possible action as an aldosterone antagonist. J. clin. Endocr.21, 1364 (1961).

    Article PubMed CAS  Google Scholar 

43. Chwalla, R. : Pathophysiologie der Prostata und der Prostatahypertrophie. Urol. int. (Basel)3, 273–296 (1956).

    Article CAS  Google Scholar 

44. Cunliffe, W.J., Shuster, S.: Pathogenesis of acne. Lancet 1969I, 7597, 685–687.

    Google Scholar 

45. Cunliffe, W.J., Shuster, S., Cassels-Smith, A.J.: The effect of topical cyproterone acetate on sebum secretion in patients with acne. Brit. J. Derm.81, 200–201 (1969).

    Article PubMed CAS  Google Scholar 

46. Cupceancu, B., Hammerstein, J.: Behandlung des Hirsutismus mit Kortikoiden, Ovulationshemmern und Antiandrogenen. Geburtsh. u. Frauenheilk.29,499–500 (1969).

    Google Scholar 

47. Dalla Pria, S., Greenblatt, R.B., Mahesh, Y.B.: An antiandrogen in acne and idiopathic hirsutism. J. invest. Derm.52, 348–350 (1969).

    Google Scholar 

48. Di Silverio, F., Gagliardi, V.: Il cancro della prostata. Nostri orientamenti terapeutici nelle forme estrogeno-resistenti. Estratto da: Bollettino Ed Atti Della Società Di Urologia Centro-Meridionale E Delle Isole Vol. V, Anno Accademico 1968–1969.

    Google Scholar 

49. Dorfman, R.I. (Ed.): Methods in Hormone Research. Bioassay 2, Part B 2nd Ed. New York-London: Academic Press 1969.

    Google Scholar 

50. Dugwekar, Y.G., Narula, R.K., Laumas, K.R.: Distribution of la-3H-chlormadinone acetate in the reproductive tract of women. Contraception7, 313–325 (1973).

    Article CAS  Google Scholar 

51. Duma, R. J.: Pathogenesis of acne. Lancet 1969I, 7601, 945.

    Google Scholar 

52. Ebling, F. J.: Steroid hormones and sebaceous secretion. In: Briggs, M.H. (Ed.). Advances Steroid. Biochem. Pharmacol. Vol. 2. London-New York: Academic Press 1970, p. 1–39.

    Google Scholar 

53. Elert, A. Jr., Schmidt-Elmendorff, H., Seuken, S., Solbach, H.G., Kaiser, E.: Einfluß von Cyproteron (Antiandrogen) auf Harn- und Plasmasteroide bei Frauen. In: Kracht, J. (Ed.). Nebenschilddrüsen und endokrine Regulation des Calciumstoffwechsels-Hypoglycämie. Glucagon. Berlin-Heidelberg-New York: Springer 1968, p. 356–361.14. Symp. Deut. Gesell. Endocrinol. Heidelberg 1968.

    Google Scholar 

54. Elger, W., Von Berswordt-Wallrabe, R.: Keine Sterilität unter dem Einfluß von kontinuierlich zugeführten Mikromengen von Cyproteronacetat bzw. von d-Norgestrel bei männlichen Ratten. Acta endocr. (Kbh.) Suppl.173, 120 (1973).

    CAS  Google Scholar 

55. Farnsworht, W. E.: Human prostatic dehydroepiandrosterone sulphate sulphatase. Steroids21, 647–664 (1973).

    Article  Google Scholar 

56. Fishman, J., Geller, J.: Effect of the antiandrogen cyproterone acetate on estradiol production and metabolism in man. Steroids16, 351–359 (1970).

    Article PubMed CAS  Google Scholar 

57. Frost, P., Gomez, E.C.: Inhibitors of sex hormones: development of experimental models. Advanc. Biol. Skin12, 403–420 (1972).

    CAS  Google Scholar 

58. Gallegos, A.J., Gonzales-Diddi, M., Merino, G., Martinez-Manautou, J.: Tissue localization of radioactive Chlormadinone acetate and progesterone in the human. Contraception1, 151–161 (1970).

    Article  Google Scholar 

59. Geissendörfer, R.: Geschlechtshormone und Entstehung der sogenannten Prostatahypertrophie. Leipzig: A. Barth 1940.

    Google Scholar 

60. Geller, J., Fishman, J.: Effect of cyproterone acetate on pituitary and gonadal function in elderly males. Clin. Res.19, 171 (1971).

    Google Scholar 

61. Geller, J., Baron, A., Warburton, A., Loh, A.: The effect of progestational agents on male gonadal and pituitary function. An. Int. Med.70, 1062 (1969) (Abstract).

    Google Scholar 

62. Geller, J., Fruchtman, B., Meyer, C., Newman, H.: Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate. J. clin. Endocr.27, 556–560 (1967).

    Article PubMed CAS  Google Scholar 

63. Geller, J., Fruchtman, B., Newman, H., Robfr T., Silva, R.: Effect of progestational agents on carcinoma of the prostate C ncei Chemother. Reports 51, Nr. 1 (1967).

    Google Scholar 

64. Geller, J., Vazakas, G., Fruchtman, G., Newman, H., Nakao, K., Loh, A.: The effect of cyproterone acetate on advanced carcinoma of the prostate. Surg. Gynec. Obstet.127, 748–758 (1968)

    PubMed CAS  Google Scholar 

65. Gerhards, E., Gutscxie, H., Riemann, J.: Biodynamik von 1,2α-Methylen-6-chlorpregna-4,6-dien-17α-acetoxy-3,20-dion (Cyproteron-acetat) nach oraler Verabreichung beim Menschen. Arzneimittel-Forsch.23, 1550–1555 (1973).

    CAS  Google Scholar 

66. Gerhards, E., Röpke, H., Schulze, P.E.: Biodynamics of 1,2α -methylene-6-chloropregna-4,6-dien-17α-ol-3,20 dione (cyproterone) in man following oral and intravenous administration. Acta endocr. (Kbh.)64, 223–252 (1970).

    Google Scholar 

67. German Clinics. Clinical Results Of Treatment With Sh 8.1041 (= Reverse Sequential Therapy Of Cyproterone Acetate And Ethinyloestradiol) For Acne, Hirsutism, Seborrhoea And Alopecia - Collaborative Study. - Bettendorf, G., Universitäts-Frauenklinik Und Poliklinik, Hamburg. Breckwoldt, M., Universitäts-Frauenklinik, Freiburg. Göbel, P., Medizinische Universitäts-Poliklinik, Tübingen. Hammerstein, J., Klinikum Steglitz Der Freien Universität Berlin, Berlin. Lauritzen, Ch., Universität Ulm, Frauenklinik, Ulm. Schmidt-Elmendorff, H., Frauenklinik Der Städtischen Krankenanstalt, Universität Düsseldorf, Düsseldorf. Taubert, H.-D., Universitäts-Frauenklinik, Frankfurt/Main. Winkler, K., Städtisches Krankenhaus Britz, Berlin. Zaun, H., Universitäts-Hautklinik, Homburg (Saar). Unpublished Results.

    Google Scholar 

68. Giorgi, E.P., Shirley, I.M., Grant, J.K., Stewart, J.C.: Androgen dynamics in vitro in the human prostate gland. Effect of cyproterone and cyproterone acetate. Biochem. J.132, 465–474 (1973).

    PubMed CAS  Google Scholar 

69. Göbel, P.: Nebennierenrinde und Hirsutismus der Frau. (The adrenal gland and hirsutism in women.J Therapiewoche18, 729–735 (1968).

    Google Scholar 

70. Göbel, P., Cyran, J.: Zusätzlicher C₁₄-Hydroxylasemangel beim adrenalen Hirsutismus der Frau (3β-Hydroxy-Steroiddehydrogenasemangel). In: Kracht, J. (Ed.). Oestrogene Hypophysentumoren. 15. Symp. Deut. Gesell. Endokrinol., Köln 1969. Berlin-Heidelberg-New York: Springer, S. 372–374, 1969.

    Google Scholar 

71. Göbel, P., Cyran, J., Frick, V., Schindler, A.E., Schwarz, M.: Antiandrogentherapie des Hirsutismus. Acta endocr. (Kbh.) Snppl.159, 100 (1972). 18. Symp. Deut. Gesell. EndokrinoL, Abstract Nr. 100.

    Google Scholar 

72. Goldzieher, J.W., Kleber, J.W., Moses, L.F., Rathmacher, R.P.: A cross-sectional study of plasma FSH and LH levels in women using sequential, combination or injectable steroid contraceptives over long periods of time. Contraception2, 225 (1970).

    Article  Google Scholar 

73. Gomez, E.C., Hsia, S.L.: In vitro metabolism of testosterone-4-¹⁴C and Δ⁴androstene-3, 17-dione-4-¹⁴C in human skin. Biochemistry7, 24–32 (1968).

    Article PubMed CAS  Google Scholar 

74. Gordon, G.G., Sonthren, A.L., Tochimoto, S., Olivo, J., Altman, K., Rand, J., Lemburger, L. : Effect of medroxyprogesterone acetate (Provera) on the metabolism and biological activity of testosterone. J. clin. Endocr.30, 449 (1970).

    Article PubMed CAS  Google Scholar 

75. Greenblatt, R.B., Zarate, A., Mahesh, Y.B.: The clinical use of 17-methyl-B-norestosterone as an antiandrogen. In: Mason, A.S., Redecilla, A.M. (Eds.). Endocrinology. Amsterdam: Exerpta Med. Found. 1965, Abstract Nr. 99, I.C.S. 6th Panamer. Congr. Endocrinol., Mexico City, p. E 176.

    Google Scholar 

76. Gueguen, J.: Etude comparative de l’élimination des stéroides urinaires après administration de Chlormadinone, d’éthinyloestradiol, de méthyléther d’éthinyloestradiol ou de noréthindrone. Gynéc. et Obstét.64, 467–481 (1965).

    CAS  Google Scholar 

77. Gupta, D., Bierich, J.R.: Investigations on the cyproterone-induced effect on the testosterone metabolism in normally developing children and adult males. Exerpta Med. Nr. 210, 3rd International Congr. on Hormonal Steroids, Abstract 414, Sept. 1970.

    Google Scholar 

78. Gupta, D., Marshall, W. A. : A longitudinal study of the urinary excretion of individual steroids in children from 3 to 7 years old. Acta endocr. (Kbh.)68, 141 (1971).

    CAS  Google Scholar 

79. Hamilton, J.B. : Male hormone substance: a prime factor in acne. J. clin. Endocr.1, 570 (1941).

    Article  Google Scholar 

80. Hammerstein, J.: Antiandrogene. Moderatorbericht, Teilnehmer: Breckwoldt, M. (Hamburg), Karschnia, R. (Frankfurt a. M.), Laschet, U. (Landeck), Lauritzen, Ch. (Ulm), Neumann, F. (Berlin), Schindler; A.E. (Tübingen), Von Schmidt-Elmendoref, H. (Düsseldorf), Taubert, H.D. (Frankfurt a. M.), Zielske, F. (Berlin). Arch. Gynäk. 214, 243–247 (1973).

    Google Scholar 

81. Hammerstein, J., Cupceancu, B.: Behandlung des Hirsutismus mit Cyproteronacetat. Dtsch. med. Wschr.94, 829–834 (1969).

    Article PubMed CAS  Google Scholar 

82. Hammerstein, J., Cupceancu, B.: Treatment of hirsutism with cyproterone acetate. In: Kracht, J. (Ed.). Oestrogene Hypophysentumoren. 15. Symp. Deut. Gesell. Endokrinol, Köln 1969. Berlin-Heidelberg-New York: Springer, p. 435–436, 1969.

    Google Scholar 

83. Hansson, V., Tveter, K.J.: Effect of anti-androgens on the uptake and binding of androgen by human benign nodular prostatic-hyperplasia in vitro. Acta endocr. (Kbh.)68, 69–78 (1971).

    CAS  Google Scholar 

84. Helge, H.: Frühreife. Mschr. Kinderheilk.121, 636–646 (1973).

    PubMed CAS  Google Scholar 

85. Helge, H., Weber, B., Hammerstein, J., Neumann, F.: Idiopathic precocious puberty: Indication for therapeutic use of cyproterone acetate, an antigonadotrophic and anti-androgenic substance ? Acta paediat. scand.58, 672–673 (1969).

    Google Scholar 

86. Heller, C.G., Nelson, W.G., Roth, A.A.: Functional prepuberal castration in males. J. clin. Endocr.3, 573–588 (1943).

    Article  Google Scholar 

87. Hertel, P. : Einfluß eines Antiandrogens (Cyproteronacetat) auf Knochenwachstum und Knochenreifung männlicher Ratten. Dissertation 1969, 84 S. Freie Universität Berlin, Medizinische Fakultät.

    Google Scholar 

88. Huggins, C., Masina, M.H., Eichelberger, L., Wharton, J.D.: Quantitative studies of protstatic secretion. I. Characteristics of the normal secretion ; the influence of thyroid, suprarenal, and testis extirpation and androgen substitution on the prostatic output. J. exp. Med.70, 543 (1939).

    Article PubMed CAS  Google Scholar 

89. Hundeiker, M., Brehm, K. : Folgen einer Langzeit-Antiandrogenbehandlung am Hoden. Z. Haut- u. Geschl -Kr.46, 28 (1971).

    Google Scholar 

90. Hunter, J.: Observations, 2nd Nicol., London 1972.

    Google Scholar 

91. Husmann, F.: Differentialdiagnose und Therapie des Hirsutismus. Münch, med. Wschr.109, 2124–2128 (1967).

    CAS  Google Scholar 

92. Husmann, F. : Neue Gesichtspunkte zur Therapie des Hirsutismus. Therapiewoche18, 83 (1968).

    Google Scholar 

93. Husmann, F.: Das Verhalten der Steroidausseheidung unter Langzeitbehandlung mit einer Oestrogen-Gestagen-Kombination. Excretion of steroids in therapy with combined estrogen-progestagen of long duration. In: Kracht, J. (Ed.) Oestrogen Hypophysentumoren. 15. Symp. Deut. Gesell. Endokrinol., Köln 1969. Berlin-Heidelberg-New York: Springer, p. 140–141, 1969.

    Google Scholar 

94. Ito, T., Horton, R.: The source of plasma dihydrotestosterone in man. J. clin. Invest.50, 1621 (1971).

    Article PubMed CAS  Google Scholar 

95. Jaffe, R.B.: Testosterone metabolism in target tissues: Hypothalamic and pituitary tissues of the adult rat and human fetus, and the immature rat epiphysis. Steroids14, 483 (1969).

    Article PubMed CAS  Google Scholar 

96. Jarpa, A., Donoso, J.: Untersuchungen über die Hemmung der Spermiogenese durch Depot-Gestagene. Andrologie1, 107–112 (1969).

    Google Scholar 

97. Johnsen, G.G.: The stage of spermatogenesis involved in the testicular hypophyseal feedback mechanism in man. Acta endocr. (Kbh.)64, 193–210 (1970).

    CAS  Google Scholar 

98. Jonsson, C.E.: In vitro uptake of tritiated testosterone and oestradiol by the lateral lobe of the hypertrophied human prostate and the accessory sex glands of the rat - a pilot study. Acta endocr. (Kbh.)61, 25–32 (1969).

    CAS  Google Scholar 

99. Jürgensen, O., Taubert, H.D.: Die Wirkung von Cyproteronacetat auf den Zyklusverlauf gesunder Frauen. Geburtsh. u. Frauenheilk. 5O, 830–837 (1970).

    Google Scholar 

100. Kaiser, H., Schmidt-Elmendorff, H., Orssich, P.: Der Einfluß eines “Antiandrogen” auf die Steroidausseheidung bei Frauen mit Hirsutismus. (The influence of an anti-androgen on the secretion of steroids in women with hirsutism.J Arch. Gynäk.204, 135–136 (1967).

     Article CAS  Google Scholar 

101. Kaiser, E., Schmidt-Elmendorff, H., Zimmermann, H., Solbach, H.G.: Harn- und Plasmasteroide unter Antiandrogen (SH 80881)-Behandlung bei Frauen mit Hirsutismus. In: Klein, E. (Ed.) Das Testosteron - Die Struma. Berlin-Heidelberg-New York: Springer 1968, p. 109–112.

     Google Scholar 

102. Kaufmann, J.: Untersuchungen zur causalen Genese der Prostatahypertrophie. Tagung Urol. Oberärzte, Basel 1967.

     Google Scholar 

103. Kent, J.R., Hill, M., Huix, F. J., Segre, E. J.: Seminal acid phosphatase content in the clinical bioassay of androgens and antiandrogens. Clin. Pharmacol. Ther.13, 205–211 (1972).

     PubMed CAS  Google Scholar 

104. Kim, M.H., Herrmann, W. L.: In vitro metabolism of dehydroisoandrosterone sulfate in foreskin, abdominal skin, and vaginal mucosa. J. clin. Endocr.28, 187–191 (1968).

     Article PubMed CAS  Google Scholar 

105. Kirschner, M.A., Bardin, C.W.: Androgen production and metabolism in normal and virilized women. Metabolism21, 667 (1972).

     Article PubMed CAS  Google Scholar 

106. Kirschner, M.A., Sinahabiahapatra, S., Zucker, I.R., Loriaux, L., Nieschlag, E.: The production, origin and role of dehydroepiandrosterone and zl5-androstendiol as androgen prehormones in hirsute women. J. clin. Endocr.37, 183–189 (1973).

     Article PubMed CAS  Google Scholar 

107. Klosterhalfen, H.: Neue Gesichtspunkte der Therapie von benignen und malignen. Neoplasien der Prostata. (New aspects in the treatment of benign and malignant neoplasias of the prostate.) In: Kracht, J. (Ed.). Haut als endokrines Erfolgsorgan-Gestagene-Geriatrische Endokrinologie des Mannes Symp. Deut. Gesell. Endokrinol. 17, 157–164 (1971). Berlin-Heidelberg-New York: Springer.

     Google Scholar 

108. Knorr, D.: Testosteron und Pubertät bei Knaben. (Testosterone and puberty in males.) Symp. Deut. Gesell. Endokrinol.16, 151–165 (1970). Berlin-Heidelberg-New York: Springer. 1

     CAS  Google Scholar 

109. Kolb, K.H., Roepke, H.: Die Pharmakokinetik von Cyproteronacetat. Eine vergleichende Untersuchung bei Mensch und Pavian. (The pharmacokinetic of eyproterone acetate. A comparing investigation in the human and the baboon.) Int. Z. klin. Pharmakol. Ther. Toxikol.1, 187–190 (1968).

     Google Scholar 

110. Krause, W.F.J.: Zur sogenannten hormonalen Kastration. Materia Med. Nordmark21, 29–35 (1969).

     Google Scholar 

111. Kulin, H.E., Reiter, E.O.: Gonadotrophin suppression by low dose oestrogen in men: evidence for differential effects upon FSH and LH. J. clin. Endocr.35, 836–839 (1972).

     Article PubMed CAS  Google Scholar 

112. Kutscher, W., Wolbergs, H.: Pröstataphosphatase. Z. Physiol. Chem.236, 237 (1935).

     Article CAS  Google Scholar 

113. Lachnit-Fixon, U.: Personal communication.

     Google Scholar 

114. Laron, Z., Pertzelman, A.: Clinical use of the antiandrogen eyproterone (SH 8.0881) in the pediatric age group. Proceedings of the Combined Annual Meeting European Club for Paediatric Research and the European Society for Paediatric Endocrinology, Vienna, August 1968, Nr. 46, pp. 48.

     Google Scholar 

115. Laschet, U., Laschet, L.: Psychopharmacotherapy of sexual offenders with cyproterone acetate. Pharmakopsychiatrie, Neuro-Psychopharmakologie4, 99–104 (1971).

     Google Scholar 

116. Lauritzen, Ch.: Beeinflussung des Endokriniums durch Antiandrogene. Arch. Gynäk. 214, 1–4, 250–251 (1973).

     Google Scholar 

117. Lee, P.A., Jaffe, R.B., Midgley, A.R., Kohen, P., Nis Wender, G.D.: Regulation of human gonadotrophins. VIII. Suppression of serum LH and FSH in adult males following exogenous testosterone administration. J. clin. Endoer.35, 636 (1972).

     Article CAS  Google Scholar 

118. Leo-Rossberg, J., Laur, S., Zielske, F., Hammerstein, J.: Reversed sequential therapy of hirsutism using cyproterone acetate. Acta endocr. (Kbh.) Suppl.152, 14 (1971).

     CAS  Google Scholar 

119. Ludescher, E., Rameis, K., Gleispach, H.: Antiandrogenbehandlung bei einem Knaben mit Pubertas praecox. Pädiat. Pädol.5, 316–325 (1969).

     Google Scholar 

120. Ludwig, E.: Hormone und Behaarung. (Hormones and hair growth.) In: Kracht, J. (Ed.). Haut als endokrines Erfolgsorgan. Gestagene. Geriatrische Endokrinologie des Mannes. 17. Symp. Döut. Gesell. Endokrinol., März 1971, p. 43–47.

     Google Scholar 

121. Mahesh, V.B., Zarate, A., Roper, B.K., Greenblatt, R.B.: Studies on the action of 17α-methyl-jB-nortestosterone as an antiandrogen. Steroids8, 297–308 (1966).

     Article CAS  Google Scholar 

122. Markewitz, M., Veenema, R.J., Fingerhut, B., Nehme-Haily, D., Sommers, S.C.: Cyproterone acetate (SH 714) effect on histology and nucleic acid synthesis in the testes of patients with prostatic carcinoma. Invest. Urol.6, 638–649 (1969).

     PubMed CAS  Google Scholar 

123. Martinez-Manautou, J., Giner-Velasquez, J., Rudel, H.: Continuous progestogen contraception: A dose relationship study with Chlormadinone acetate. Fértil, and Steril.18, 57–62 (1967).

     CAS  Google Scholar 

124. Mauermayer, W.: Cyproterone therapy in prostatic cancer stage III and IV. In: Raspé, G., Brosig, W. (Eds.). International Symposium on the Treatment of Carcinoma of the Prostate, Berlin, Nov. 1969. Oxford-Edinburgh-New York: Pergamon Press, Vieweg 1971, p. 179–180. Life Sciences Monographs.

     Google Scholar 

125. Meiers, G.G., Schmidt-Elmendorff, H:, Jost, B., Pfaffenrath, V.: Trichometrische Objektivierung und Verlaufskontrolle des Hirsutismus. preliminary report - Preview of the “102. Tagung der Rheinisch-Westfälischen Dermatologen”, Bonn, Okt. 1973.

     Google Scholar 

126. Mauvais-Jarvis, P., Charransol, G., Bobas-Masson, F.: Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity. J. clin. Endocr.36, 452–459 (1973).

     Article PubMed CAS  Google Scholar 

127. Mellin, P.: Cyproterone therapy in prostatic cancer stage IV. In: Raspé, G., Brosig, W. (Eds.). International Symposium on the Treatment of Carcinoma of the Prostate, Berlin, Nov. 1969. Oxford-Edinburgh-New York: Pergamon Press, Vieweg 1971, p. 180. Life Sciences Monographs.

     Google Scholar 

128. Menking, M., Blunck, W., Wiebel, J., Stahnke, N., Willig, R.P., Bierich, J.R.: Über Frühreife. IV. Mitteilung: Therapie der Pubertas praecox. Mschr. Kinderheilk.119, 19–22 (1971).

     PubMed CAS  Google Scholar 

129. Morse, H.C., Leach, D.R., Rowley, M.J., Heller, C.G.: Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men. J. Reprod. Fértil.32, 365–378 (1973).

     Article PubMed CAS  Google Scholar 

130. Moszkowicz, L.: Sexualzyklus, Mastopathie und Geschwulstwachstum der Mamma. Arch. klin. Chir.144, 133–161 (1927).

     Google Scholar 

131. Moszkowicz, L.: Prostatahypertrophie und Intersexualität. Virchows Arch. path. Anat.284, 408–465 (1932).

     Google Scholar 

132. Moszkowicz, L.: Biologische Grundlagen zum Problem des männlichen Klimakteriums. Wien. klin. Wschr.50, 1443–1449 (1937).

     Google Scholar 

133. Nagamatsu, G.R.: Use of cyproterone acetate in prostatic cancer stages III and IV. In: Life Sciences Monographs. International Symposium on the Treatment of Carcinoma of the Prostate,Berlin, Nov. 1969, p. 173–174, (Raspé, G., Brosig, W., Eds.). Oxford-Edingburgh-New York: Pergamon Press, Vieweg 1971.

     Google Scholar 

134. Neale, C., Krebs, D., Bettendorf, G.: Behandlung der Akne, des Hirsutismus und der Alopezie mit Cyproteronacetat und Aethinyloestradiol. Acta, endocr. (Kbh.) Suppl.152, 13 (1971).

     CAS  Google Scholar 

135. Nehme-Haily, D., Osario, D.G., Veenema, R.J., Markewitz, M.: Resultados preliminares con el uso del acetato de ciproterona (SH-714) en el carcinoma prostatico avanzado. Ref. Venez. Urol.20, 19–26 (1968).

     CAS  Google Scholar 

136. Nelson, U.M., Rakoff, A.E.: Hirsutism and acne treated by an androgen antagonist. Obstet. Gynaecol.36, 748–752 (1970).

     CAS  Google Scholar 

137. Neumann, F.: Methods for evaluating anti-sexual hormones. Symp. on Methods in Drug Evaluation, Mailand 1965. North-Holland Publ. Company, Amsterdam, p. 548, 1966.

     Google Scholar 

138. Neumann, F.: Chemische Konstitution und pharmakologische Wirkung. In: Junkmann, K. (Ed.). “Gestagene”. Handbuch der experimentellen Pharmakologie Band XXII/I, Kapitel VI, p. 680–1025, 1968. Berlin: Springer.

     Google Scholar 

139. Neumann, F., Von Berswordt-Wallrabe, R., Elger, W., Steinbeck, H.: Hormonhemmer-Untersuchungen mit Testosteron-Antagonisten. 18. Colloqium der Gesellschaft für physiologische Chemie, April 1967, Mosbach/Baden, S. 218–248. Berlin-Heidelberg-New York: Springer 1967.

     Google Scholar 

140. Neumann, F., Von Berswordt-Wallrabe, R., Elger, W., Steinbeck, H., Hahn, J.D., Kramer, M.: Aspect of androgen-dependent events as studied by anti-androgens. Recent Progr. Hormone Res.26, 337–410 (1970).

     CAS  Google Scholar 

141. O’Malley, B.W.: Mechanisms of action of steroid hormones. New England. J. Med.284, 370–377 (1971).

     Google Scholar 

142. Paetzmann, H., Elsaesser, F., Haller, J., Haeffele, R.: Suppression and stimulation of plasma testosterone and DHT in hirsute women. Acta endocr. (Kbh.) 72, Suppl.173, 170 (1973).

     CAS  Google Scholar 

143. Peeters, F., Oeyen, R., Van Roy, M.: Ovarian inhibition with progestogens: A study of the recuperation stage. Int. J. Fertil.9, 111–120 (1964).

     PubMed CAS  Google Scholar 

144. Peterson, N.T., Midgley, A.R., Jaffe, R.B.: Regulation of human gonadotrophins. III. Luteinizing hormone level and follicle-stimulating hormone in sera from adult males. J. clin. Endocr.28, 1473 (1968).

     Article PubMed CAS  Google Scholar 

145. Petry, R., Mauss, J., Rausch-Stroomann, J.G., Vermeulen, A.: Reversible inhibition of spermatogenesis in men. Horm. Metab. Res.4, 386–388 (1972).

     Article PubMed CAS  Google Scholar 

146. Petry, R., Rausch-Strooman, J. G., Mauss, J., Senge, T.: Der Einfluß von Cyproterone auf die Funktion der Hypophyse und die männliche Keimdrüse bei Gesunden. In: Kracht, J. (Ed.). Oestrogene Hypophysentumoren. 15. Symp. Deut. Gesell. Endokrinol., Köln 1969. Berlin-Heidelberg-New York: Springer, S. 432–434, 1969.

     Google Scholar 

147. Pochi, P. E., Strauss, J. S.: Effect of sequential mestranol-Chlormadinone on sebum production. Ärch. Derm.95, 47–49 (1967).

     Article PubMed CAS  Google Scholar 

148. Poem, P.E., Strauss, J.S.: Sebaceous gland response in man to the administration of testosterone, zi4-androstenedione, and dehydroisoandrosterone. J. invest. Derm.52, 32 (1969).

     Google Scholar 

149. Pochi, P.E., Strauss, J.S., Mescon, H.: The role of adrenocortical steroids in the control of human sebaceous gland activity. J. invest. Derm.41, 391 (1963).

     Article PubMed CAS  Google Scholar 

150. Popelier, G.: Behandlung des Prostata-Carcinoms mit Gestagenen. Urologe A12, 134–139 (1973).

     PubMed CAS  Google Scholar 

151. Prasad, M.R.N., Rajalakshmi, M., Gupta, G., Karkun, T.: Control of epididymal function. J. Reprod. Fertil. Suppl.18, 215–222 (1973).

     PubMed CAS  Google Scholar 

152. Prasad, M.R.N., Singh, S.P., Rajalakshmi, M.: Fertility control in male rats by continuous release of microquantities of cyproterone acetate from subcutaneous silastic capsules. Contraception2, 165–178 (1970).

     Article CAS  Google Scholar 

153. Rager, K., Huenges, R., Gupta, D., Bierich, J.: Einfluß von Cyproteronacetat auf die körperliche Entwicklung und die Steroidausscheidung bei Pubertas praecox. Klin. Wschr.51, 774–775 (1973).

     Google Scholar 

154. Rager, K., Huenges, R., Gupta, D., Bierich, J.R.: The treatment of precocious puberty with cyproterone acetate. Acta endocr. (Kbh.)74, 399–408 (1973).

     CAS  Google Scholar 

155. Rajalakshmi, M., Singh, S.P., Prasad, M.R.N.: Effects of microquantities of cyproterone acetate released through silastic capsules on the histology of the epididymis of the rat. Contraception3, 335–346 (1971).

     Article CAS  Google Scholar 

156. Rangno, R.E., Mcleod, P. J., Ruedy, J., Ogilvie, R.I.: Treatment of benign prostatic hypertrophy with medrogestone. Clin. Pharmacol. Ther.12, 658–665 (1971).

     PubMed CAS  Google Scholar 

157. Rasmusson, G.H., Chen, A., Reynolds, G.F., Patanelli, D.J., Patchett, A.A., Arth, G.E.: Antiandrogens. 2/,3/a-Tetrahydrofuran-2’-spiro-17-(l,2a-methylene-4-androsten-3-ones). J. Med. Chem.15, 1165–1168 (1972).

     Article PubMed CAS  Google Scholar 

158. Rausch-Stroomann, J.G., Petry, R., Hocevar, V., Mauss, J., Senge, T.: Influence of an antiandrogen (cyproterone) on the gonadotrophic function of the pituitary gland, on the gonads and on metabolism in normal men. Acta endocr. (Kbh.)63, 595–608 (1970).

     CAS  Google Scholar 

159. Rayner, P.H.W., Rttdd, R.T., Jivani, S.K.M.: Cerebral sexual precocity treated with cyproterone acetate. Archives of Diseases of Childhood: Submitted for publication.

     Google Scholar 

160. Reisert, P.M., V.Z. Mühlen, A.: Untersuchungen über die Gonaden- und Nebennieren- rindenfunktion unter einer Gestagen-Therapie (Chlormadinonacetat). Arzneimittel- Forsch.19, 1279–1283 (1969).

     CAS  Google Scholar 

161. Roberts, H.J.: Estrogenic management of benign prostatism, including early and poor risk cases: 7-year experience. J. Amer. Geriat. Soc.14, 657–701 (1966).

     PubMed CAS  Google Scholar 

162. Rongone, E.L.: Testosterone metabolism by human male mammary skin. Steroids7, 489–504 (1966).

     Article PubMed CAS  Google Scholar 

163. Roth, A.A.: Familial Eunuchoidism: The Laurence-Moon. J. Urol. (Baltimore)57, 427–445 (1947).

     CAS  Google Scholar 

164. Rothauge, C.F., Breitwieser, P., Weldberger, J.E.: Probleme der hormonalen Behandlung des Prostatakarzinoms. Z. Allgemeinmed.47, 337–344 (1971).

     PubMed CAS  Google Scholar 

165. Rothauge, C.F., Breitwieser, P., Wildberger, J.E., Nöske, H.D.: Neue Aspekte der Prostatakarzinomtherapie. Therapiewoche22, 3046–3057 (1972).

     Google Scholar 

166. Sansone, G., Reisner, R.M.: Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin-a possible pathogenic factor in acne. J. invest. Derm.56, 366 (1971).

     Article PubMed CAS  Google Scholar 

167. Schaefer, H.: The quantitative differentiation of sebum excretion using physical methods. J. Soc. Cosmetic Chemists24, 331–353 (1973).

     CAS  Google Scholar 

168. Schaefer, H., Kuhn-Bussius, H.: Methodik zur quantitativen Bestimmung der menschlichen Talgsekretion. Arch. klin. exp. Derm.238, 429–431 (1970).

     CAS  Google Scholar 

169. Schirren, C., Immel, L.: Hormonale Therapie der Akne vulgaris (Ovulationshemmer bei prämenstrueller Akne). Münch, med. Wschr.111, 1742–1747 (1969).

     CAS  Google Scholar 

170. Schmidt-Elmendorff, H., Kaiser, E.: Der Einfluß eines Antiandrogens auf die Gonadotropinausscheidung bei Frauen mit Hirsutismus, mit Adrenogenitalem Syndrom (AGS) und bei Frauen in der Menopause. In: Klein, E. (Ed.). Das Testosteron. - Die Struma. 13. Symp. Deut. Gesell. Endokrinol., Würzburg 1967. Berlin-Heidelberg-New York: Springer 1968, S. 113–115.

     Google Scholar 

171. Schmidt-Elmendorff, H., Kaiser, E., Bauchwitz, M.A.: Einfluß eines Antiandrogens auf die Gonadotropinausscheidung, das Endometrium und den Vaginalsmear bei Frauen mit Hirsutismus. Zbl. Gynäk.89, 772 (1967).

     Google Scholar 

172. Schmidt-Elmendorff, H., Kaiser, E., Bauchwitz, M.A.: Einfluß eines Antiandrogens auf die Gonadotropinausscheidung, das Endometrium und den Vaginalsmear bei Frauen mit Hirsutismus. Arch. Gynäk.204, 133–135 (1967).

     Article CAS  Google Scholar 

173. Schoonees, R., Reynoss, G., De Klerk, S.N., Murphy, G.P.: Antiandrogen effects on canine prostatic secretion. Invest. Urol.10, 434–437 (1973).

     PubMed CAS  Google Scholar 

174. Schoonees, R., Schalch, D.S., Murphy, G.P.: The hormonal effects of antiandrogen (SH-714) treatment in man. Invest. Urol.8, 635–639 (1971).

     PubMed CAS  Google Scholar 

175. Sciarra, F., Sorcini, G., Piro, C.: Determination of testosterone and z/4-androstenedione in plasma by competitive protein binding analysis. Folia endocr. (Roma)3, 271 (1969).

     Google Scholar 

176. Sciarra, F., Sorcini, G., Di Selverio, F., Gagliardi, V.: Biosintesi in vitro degli androgeni nel testicolo di soggetti con cancro della prostata, trattati con estrogeni e ciproterone acetato. Folia endocr. (Roma)23, 264–277 (1970).

     CAS  Google Scholar 

177. Sciarra, F., Sorcini, G., Di Selverio, F., Gagliardi, V.: Testosterone and 4-andro-stenedione concentration in peripheral and spermatic venous blood of patients with prostatic adenocarcinoma. J. Steroid. Biochem.2, 313–320 (1971).

     Article  Google Scholar 

178. Scott, W.W.: Cyproterone acetate treatment of disseminated prostatic cancer and benign nodular hyperplasia. In: Raspé, G., Brosig, W. (Eds.). International Symposium on the Treatment of Carcinoma of the Prostata, Berlin, Nov. 1969. Life Science Monograph 1, 161–163 and 173–180. Oxford: Pergamon Press 1971.

     Google Scholar 

179. Scott, W.W., Schermer, H.K.A.: A new oral progestational steroid effective in treating prostatic cancer. Trans. Amer. Ass. gen.-urin. Surg.58, 54–60 (1966).

     CAS  Google Scholar 

180. Senge, T., Richter, K.D., Reis, H.E.: Der Einfluß von Androgenen, Östrogenen und Antiandrogenen auf menschliches Prostataadenom und -carcinomgewebe nach Hetero-transplantation auf neugeborene Ratten. Junkmann-Schöller price 1973, 80 S. Schering AG, Berlin/Bergkamen.

     Google Scholar 

181. Shuster, S.: The bioassay of androgen, anti-androgen and other hormones on the sebaceous gland. Brit. J. Derm. 82, Suppl.6, 15–18 (1970).

     Article  Google Scholar 

182. Smith, R.B., Walsh, P.C., Goodwin, W.E.: Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J. Urol. 110/1, 106–108 (1973).

     PubMed CAS  Google Scholar 

183. Soffer, L.: Diseases of the endocrine glands. Ed. 2. Philadelphia: Lea and Febiger, p. 138–144, 1956.

     Google Scholar 

184. Sorcini, G., Sciarra, P., Di Silverio, F., Fraioli, F.: Further studies on plasma androgens and gonadotropins after cyproterone acetate (SH 714). Folia endocr. (Roma) 24, 196–201 (1971).

     CAS  Google Scholar 

185. Städtler, F., Horn, H.J.: Veränderungen an menschlichen Hoden während einer Antiandrogen-Behandlung. Dtsch. med. Wschr. 98, 1013–1019 (1973).

     Article PubMed  Google Scholar 

186. Stahl, N.L., Teeslink, C.R., Beauchamps, O., Greenblatt, R.B.: Serum testosterone levels in hirsute women: A comparison of adrenal, ovarian and peripheral vein values. Obstet. Gynecol. 41, 650–654 (1973).

     PubMed CAS  Google Scholar 

187. Strauss, J.S., Pochi, P.E.: The quantitative gravimetric determination of sebum production. J. invest. Derm. 36, 293 (1961).

     Google Scholar 

188. Strauss, J.S., Pochi, P.E.: Assay of anti-androgens in man by the sebaceous gland response. Brit. J. Derm. 82, Suppl. 6, 33–42 (1970).

     Article CAS  Google Scholar 

189. Strauss, J.S., Pochi, P.E., Sarda, J.R., Wotiz, H.H.: Effect of oral and topical 17α-methyl-J5-nortestosterone on sebum production and plasma testosterone. J. invest. Derm. 52, 95–99 (1969).

     PubMed CAS  Google Scholar 

190. Sturde, H.C.: Der Einfluß des Antiandrogens Cyproterone auf die Ejaculatbefunde junger Männer einschließlich der Sperma-Prostaglandine. Arch. Derm. Forsch. 241, 86–95 (1971).

     Article CAS  Google Scholar 

191. Tamm, J.: Diskussion remark to “Antiandrogenic activitie of some pregnane derivates”, by Kraft, H.-G., Harting, J. In: Tamm, J. (Ed.). Testosterone. Proc. Workshop Conf., Tremsbuettel 1967. Stuttgart: Gerorg Thieme, 1968, p. 150.

     Google Scholar 

192. Tamm, J., Beischer, W.: The urinary excretion of testosterone, and epitestosterone in females following intravenous infusion of testosterone before and during treatment with an anti-androgen (cyproterone). Acta endocr. (Kbh.) 59, 454–458 (1968).

     CAS  Google Scholar 

193. Tamm, J., Voigt, K.D., Schönrock, M., Ludwig, E.: The effect of orally administered cyproterone on the sebum production on human subjects. Acta endocr. (Kbh.) 63, 50–58 (1970).

     CAS  Google Scholar 

194. Teller, W.M., Murset, G., Schellong, G.: Urinary C19 and C21 steroid patterns in isosexuel precocious puberty during long-term treatment with gestagens. Acta paediat. scand. 58, 385–392 (1969).

     Article PubMed CAS  Google Scholar 

195. Tochimoto, S., Olivo, J., Southren, A.L.: Studies of plasma β-globulin: Sex difference and effect of ethinyl estradiol and testosterone. Proc. Soc. exp. Biol. (N.Y.) 134, 700–702 (1970).

     CAS  Google Scholar 

196. Tveter, K.J.: Effect of Ha-metliyl-.B-nortestosterone (SK and F 7690) on the binding in vitro of 5a-dihydrotestosterone to maeromolecular components from the rat ventral prostate. Acta endocr. (Kbh.) 66, 352–356 (1971).

     CAS  Google Scholar 

197. Vahlensieck, W.: Miktionsstörungen bei Prostataerkrankungen. Fortschr. Med. 88, 1183–1187 (1970).

     Google Scholar 

198. Vahlensieck, W., Gödde, S.: Behandlung der Prostatahypertrophie mit Gestagenen. Münch, med. Wschr.110, 1573–1577 (1968).

     CAS  Google Scholar 

199. Veebiena, R.J.: Cyproterone therapy in prostatic cancer stage IV. In: Raspe, G., Brosig, W. (Eds.). International Symposium on the Treatment of Carcinoma of the Prostate, Berlin, Nov. 1969. Oxford-Edinburgh-New York: Pergamon Press, Vieweg 1971, p. 179. Life Sciences Monographs.

     Google Scholar 

200. Vermeulen, A., Stoica, T., Verdonck, L.: The apparent free testosterone concentration, an index of androgenicity. J. clin. Endocr.33, 759 (1971).

     Article PubMed CAS  Google Scholar 

201. Voigt, K.D., Apostolakis, M., Klosterhalfen, H.: The influence of cyproterone treatment on the excretion of steroids in male patients. In: Tamm, J. (Ed.). Testosterone. Proc. Workshop Conf., Tremsbuettel, April 1967. Stuttgart: Georg Thieme 1968, p. 152–155.

     Google Scholar 

202. Voigt, W., Fernandez, E.P., Hsia, S.L.: Transformation of testosterone into 17β-hydroxy-5a-androstan-3-one by microsomal preparations of human skin. J. biol. Chem.245, 5594 (1970).

     PubMed CAS  Google Scholar 

203. Vosbeck, K., Keller, P.J.: The influence of antiandrogens on the excretion of FSH, LH and 17-ketosteroids in males. Horm. Metab. Res.3, 273–276 (1971).

     Article PubMed CAS  Google Scholar 

204. Voss, H.E., Oertel, G.: Androgene I. p. 474–501 (1973). In: Handbuch Der Experimentellen Pharmakologie. Handbook Of Experimental Pharmacology, New Series Xxxv/1. Eichler, O., Rensselaer, A.F., Herken, H., Welch, A.D. (Eds.). Berlin-Heidelberg-New York: Springer 1973.

     Google Scholar 

205. Wannow, E.: Untersuchungen über das Verhalten der 17-Ketosteroid-Fraktionen im Harn von Frauen mit Hirsutismus unter der Behandlung mit dem Antiandrogen “Cyproterone”. Dissertation, 144 S. (1969), Universität Düsseldorf, Medizinische Fakultät.

     Google Scholar 

206. Van Way Jen, R.G.A., Van Den Ende, A.: Clinical-pharmacological investigation of cyproterone acetate. Gynecol. Invest.2, 1–6, 282–289 (1971/1972).

     Google Scholar 

207. Wein, A.J., Murphy, J. J.: Experience in the treatment of prostatic carcinoma with cyproterone acetate. J. Urol. (Baltimore)109, 1, 68–70 (1973).

     CAS  Google Scholar 

208. Weinheimer, B., Oertel, G. W., Leppla, W., Blaise, H., Bette, H.: In: Plasma Steroid Concentrations Of Adrenal Venous Blood From Women With And Without Hirsutism. Vermeulen, A. (Ed.). Androgens in normal and pathological conditions. Amsterdam, London: Excerpta Medica Found, p. 36–41, 1966.

     Google Scholar 

209. Werder, K., Von Ettinger, B., Thenaers, G.C., Forsham, P.: Plasma testosterone in hirsute women: diagnostic significance of stimulation-suppression tests. 17. Symp. Deut. Gesell. Endokrinol., Abstract Nr. 16. Acta endocr. (Kbh.) Suppl.152, 16 (1971).

     Google Scholar 

210. Wheeler, C.E., Cawley, E.P., Gray, H.T., Curtis, A.C.: Gynecomastia: a review and an analysis of 160 cases. Ann. intern. Med.40, 985–1004 (1954).

     PubMed CAS  Google Scholar 

211. White, J. W.: The results of double castration in hypertrophy of the prostate. Ann. Surg. 22, 1895.

     Google Scholar 

212. Wilson, J.D., Walker, J.D.: The conversion of testosterone to 5a-androstan-17β-ol-3-one (dihydrotestosterone) by skin slices of man. J. clin. Invest.48, 371 (1969).

     Article PubMed CAS  Google Scholar 

213. Winkler, K.: Akne und Hormone. Aesthet. Med.16, 315–324 (1967).

     CAS  Google Scholar 

214. Winkler, K.: La valleur des anti-androgens en dermatologie. Ann. Derm. Syph. (Paris)95, 2, 147–153 (1968).

     CAS  Google Scholar 

215. Winkler, K.: Die Antiandrogene in der Dermatologie (Gravimetrische Fettbestimmung während Cyproteronanwendung). Arch. klin. exp. Derm.233, 296–302 (1968).

     Article PubMed CAS  Google Scholar 

216. Winkler, K.: Hormonbehandlung in der Dermatologie. 2. Aufl. Berlin: De Gruyter 1969.

     Google Scholar 

217. Winkler, K.: Klinische Aspekte der Steroidwirkung an der Haut. In: Kracht, J. (Ed.). Haut als endokrines Erfolgsorgan-Gestagene-Geriatrische Endokrinologie des Mannes. Berlin-Heidelberg-New York: Springer 1971, p. 157–164.

     Google Scholar 

218. Winkler, K.: Der Einfluß von Hormonen, im besonderen von Antiandrogenen, auf Seborrhoe und Haarwachstum. Z. Haut- u. Geschl.-Kr.46, 75–78 (1971).

     CAS  Google Scholar 

219. Winkler, K.: Orale Kontrazeptiva und Acne vulgaris. Hautarzt23, 241–243 (1972).

     PubMed CAS  Google Scholar 

220. Winkler, K., Schaefer, H.: Das Verhalten der Talgsekretion während der Behandlung der Acne mit Cyproteronacetat und Äthinylöstradiol. Arch. Derm. Forsch.247, 259–264 (1973).

     Article CAS  Google Scholar 

221. Yanaihara, T., Troen, P.: Studies on the human testis. 3. Effect of estrogen on testosterone formation in human testis in vitro. J. clin. Endocr.34, 968–973 (1972).

     Article PubMed CAS  Google Scholar 

222. Yen, S.S.C., Tsai, C.C.: The biphase pattern in the feedback action of ethinyloestradiol on the release of pituitary FSH and LH. J. clin. Endocr.33, 882 (1971).

     Article PubMed CAS  Google Scholar 

223. Zarate, A., Greenblatt, R.B., Castelazo-Ayala, L.: Tratamiento del hirsutismo “idiopatico” mediant inhibición ovarica, inhibición suprarenal y con un agente anti-androgenico. Ginec. Obstet. Méx.23, 457–462 (1968).

     PubMed CAS  Google Scholar 

224. Zarate, A., Mahesh, V.B., Greenblatt, R.B.: Effect of an antiandrogen, 17α-methyl-β-nortestosterone, on acne and hirsutism. J. clin. Endocr.26, 12, 1394–1398 (1966).

     Article PubMed CAS  Google Scholar 

225. Zaun, H.: Beobachtungen zur Wirkung von Cyproteroneacetat auf das Haarwachstum. Acta endocr. (Kbh.) Suppl.152, 17 (1971).

     CAS  Google Scholar 

226. Zaun, H.: Zur Wirkung antiandrogener Hormone auf das Haarwachstum. Parfüm. Kosmet.53, 29–31 (1972).

     Google Scholar 

227. Zaun, H.: Haarwachstumsstörungen nach Sexualhormontherapie, Sexualhormontherapie bei Haarwuchsstörungen. Hautarzt24, 1–6 (1973).

     PubMed CAS  Google Scholar 

228. Zielske, F., Dreykluft, R., Magnus, U., Hammerstein, J.: Reversed sequential therapy of hisutism using cyproterone acetate. II. Hormonal analyses. Acta endocr. (Kbh.) Suppl. 152, Nr. 15 (1971).

     Google Scholar 

229. Zielske, F., Leo-Rossberg, I., Dreykluft, R., Römmler, A., Hammerstein, J.: Treatment of hirsutism and other signs of virilism with a reversed sequential administration of cyproterone acetate and ethinyloestradiol, clinical and endocrinological aspects. Acta endocr. (Kbh.) Suppl.155, 172 (1971).

     Google Scholar 

Addendum

1. Braendle, W., Boess, H., Breckwoldt, M., Leven, Ch., Bettendorf, G.: Wirkung und Nebenwirkung der Cyproteronacetatbehandlung. Areh. Gynäk. 1974 (in press).

   Google Scholar 

2. Meinhof, W., Kaiser, E., Loch, E.G.: Die androgenetisehe Acne der Frau. Hautarzt 25/1, 34–38 (1974).

   PubMed CAS  Google Scholar 

3. Irving, W. J., Barnes, E.W., Hunter, W.H., Ismail, A.A.A.: Effect of cyproterone acetate on steroid levels and hirsutism in two female patients in a long-term study. J. Endocr. 61/1, 32–33 (1974).

   Google Scholar 

Download references